A novel cardiac hypertrophic factor, neurotrophin-3, is paradoxically downregulated in cardiac hypertrophy

Haruko Kawaguchi-Manabe, Masaki Ieda, Kensuke Kimura, Tomohiro Manabe, Satoru Miyatake, Hideaki Kanazawa, Takashi Kawakami, Satoshi Ogawa, Makoto Suematsu, Keiichi Fukuda

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

The neurotrophin family plays pivotal roles in the development of the nervous system. Recently, the role of the neurotrophin in non-neural tissue has been extensively investigated. Among them, neurotrophin-3 and its receptor TrkC are critical for embryonic heart development, though little is known about neurotrophin-3/TrkC function in adult heart. Moreover, the expressions of other neurotrophin and Trk families in the cardiovascular system have not been fully determined. In adult and neonatal rats, only TrkC mRNA was expressed more abundantly in heart than aorta among the neurotrophin receptors, while all neurotrophins were equally expressed in the cardiovascular system. Immunohistochemistry confirmed the protein expressions of neurotrophin-3/TrkC in rat ventricles. In primary-cultured rat cardiomyocytes, neurotrophin-3 strongly activated p38 mitogen-activated protein kinase, extracellular signal-regulated kinase 1/2, and Jun N-terminal kinase pathways in Western blot analysis. In Northern blot analysis, neurotrophin-3 strongly increased mRNA expressions of cardiac hypertrophic markers (skeletal α-actin and atrial natriuretic peptide) in cardiomocytes. [3H]-phenylalanine uptake into cardiomyocytes, myofilament reorganization, and cardiomyocyte size were also augmented with neurotrophin-3 stimulation, indicating that neurotrophin-3 is a novel cardiac hypertrophic factor. Unexpectedly, neurotrophin-3 was downregulated in cardiac hypertrophy induced by pressure overload (in vivo), and in cardiomyocyte hypertrophy evoked by endothelin-1 stimulation (in vitro). Interestingly, the cell size and BNP mRNA expression level (markers of hypertrophy) were greater in cardiomyocytes treated with both neurotrophin-3 and endothelin-1 than in those stimulated with endothelin-1 alone. These findings demonstrate that neurotrophin-3 is a unique hypertrophic factor, which is paradoxically downregulated in cardiac hypertrophy and might counteract hypertrophic change.

Original languageEnglish
Pages (from-to)385-392
Number of pages8
JournalLife Sciences
Volume81
Issue number5
DOIs
Publication statusPublished - 2007 Jul 12

Fingerprint

Neurotrophin 3
Cardiomegaly
Down-Regulation
Cardiac Myocytes
Nerve Growth Factors
Endothelin-1
Rats
Cardiovascular system
Cardiovascular System
Messenger RNA
Hypertrophy
trkC Receptor
Nerve Growth Factor Receptors
Mitogen-Activated Protein Kinase 3
Myofibrils
Mitogen-Activated Protein Kinase 1
Neurology
Atrial Natriuretic Factor
p38 Mitogen-Activated Protein Kinases
Phenylalanine

Keywords

  • Cardiac hypertrophy
  • Cardiomyocyte
  • Heart
  • Neurotrophin-3
  • TrkC

ASJC Scopus subject areas

  • Pharmacology

Cite this

A novel cardiac hypertrophic factor, neurotrophin-3, is paradoxically downregulated in cardiac hypertrophy. / Kawaguchi-Manabe, Haruko; Ieda, Masaki; Kimura, Kensuke; Manabe, Tomohiro; Miyatake, Satoru; Kanazawa, Hideaki; Kawakami, Takashi; Ogawa, Satoshi; Suematsu, Makoto; Fukuda, Keiichi.

In: Life Sciences, Vol. 81, No. 5, 12.07.2007, p. 385-392.

Research output: Contribution to journalArticle

Kawaguchi-Manabe, Haruko ; Ieda, Masaki ; Kimura, Kensuke ; Manabe, Tomohiro ; Miyatake, Satoru ; Kanazawa, Hideaki ; Kawakami, Takashi ; Ogawa, Satoshi ; Suematsu, Makoto ; Fukuda, Keiichi. / A novel cardiac hypertrophic factor, neurotrophin-3, is paradoxically downregulated in cardiac hypertrophy. In: Life Sciences. 2007 ; Vol. 81, No. 5. pp. 385-392.
@article{e5e94dacd566418ba678865922cb8f03,
title = "A novel cardiac hypertrophic factor, neurotrophin-3, is paradoxically downregulated in cardiac hypertrophy",
abstract = "The neurotrophin family plays pivotal roles in the development of the nervous system. Recently, the role of the neurotrophin in non-neural tissue has been extensively investigated. Among them, neurotrophin-3 and its receptor TrkC are critical for embryonic heart development, though little is known about neurotrophin-3/TrkC function in adult heart. Moreover, the expressions of other neurotrophin and Trk families in the cardiovascular system have not been fully determined. In adult and neonatal rats, only TrkC mRNA was expressed more abundantly in heart than aorta among the neurotrophin receptors, while all neurotrophins were equally expressed in the cardiovascular system. Immunohistochemistry confirmed the protein expressions of neurotrophin-3/TrkC in rat ventricles. In primary-cultured rat cardiomyocytes, neurotrophin-3 strongly activated p38 mitogen-activated protein kinase, extracellular signal-regulated kinase 1/2, and Jun N-terminal kinase pathways in Western blot analysis. In Northern blot analysis, neurotrophin-3 strongly increased mRNA expressions of cardiac hypertrophic markers (skeletal α-actin and atrial natriuretic peptide) in cardiomocytes. [3H]-phenylalanine uptake into cardiomyocytes, myofilament reorganization, and cardiomyocyte size were also augmented with neurotrophin-3 stimulation, indicating that neurotrophin-3 is a novel cardiac hypertrophic factor. Unexpectedly, neurotrophin-3 was downregulated in cardiac hypertrophy induced by pressure overload (in vivo), and in cardiomyocyte hypertrophy evoked by endothelin-1 stimulation (in vitro). Interestingly, the cell size and BNP mRNA expression level (markers of hypertrophy) were greater in cardiomyocytes treated with both neurotrophin-3 and endothelin-1 than in those stimulated with endothelin-1 alone. These findings demonstrate that neurotrophin-3 is a unique hypertrophic factor, which is paradoxically downregulated in cardiac hypertrophy and might counteract hypertrophic change.",
keywords = "Cardiac hypertrophy, Cardiomyocyte, Heart, Neurotrophin-3, TrkC",
author = "Haruko Kawaguchi-Manabe and Masaki Ieda and Kensuke Kimura and Tomohiro Manabe and Satoru Miyatake and Hideaki Kanazawa and Takashi Kawakami and Satoshi Ogawa and Makoto Suematsu and Keiichi Fukuda",
year = "2007",
month = "7",
day = "12",
doi = "10.1016/j.lfs.2007.05.024",
language = "English",
volume = "81",
pages = "385--392",
journal = "Life Sciences",
issn = "0024-3205",
publisher = "Elsevier Inc.",
number = "5",

}

TY - JOUR

T1 - A novel cardiac hypertrophic factor, neurotrophin-3, is paradoxically downregulated in cardiac hypertrophy

AU - Kawaguchi-Manabe, Haruko

AU - Ieda, Masaki

AU - Kimura, Kensuke

AU - Manabe, Tomohiro

AU - Miyatake, Satoru

AU - Kanazawa, Hideaki

AU - Kawakami, Takashi

AU - Ogawa, Satoshi

AU - Suematsu, Makoto

AU - Fukuda, Keiichi

PY - 2007/7/12

Y1 - 2007/7/12

N2 - The neurotrophin family plays pivotal roles in the development of the nervous system. Recently, the role of the neurotrophin in non-neural tissue has been extensively investigated. Among them, neurotrophin-3 and its receptor TrkC are critical for embryonic heart development, though little is known about neurotrophin-3/TrkC function in adult heart. Moreover, the expressions of other neurotrophin and Trk families in the cardiovascular system have not been fully determined. In adult and neonatal rats, only TrkC mRNA was expressed more abundantly in heart than aorta among the neurotrophin receptors, while all neurotrophins were equally expressed in the cardiovascular system. Immunohistochemistry confirmed the protein expressions of neurotrophin-3/TrkC in rat ventricles. In primary-cultured rat cardiomyocytes, neurotrophin-3 strongly activated p38 mitogen-activated protein kinase, extracellular signal-regulated kinase 1/2, and Jun N-terminal kinase pathways in Western blot analysis. In Northern blot analysis, neurotrophin-3 strongly increased mRNA expressions of cardiac hypertrophic markers (skeletal α-actin and atrial natriuretic peptide) in cardiomocytes. [3H]-phenylalanine uptake into cardiomyocytes, myofilament reorganization, and cardiomyocyte size were also augmented with neurotrophin-3 stimulation, indicating that neurotrophin-3 is a novel cardiac hypertrophic factor. Unexpectedly, neurotrophin-3 was downregulated in cardiac hypertrophy induced by pressure overload (in vivo), and in cardiomyocyte hypertrophy evoked by endothelin-1 stimulation (in vitro). Interestingly, the cell size and BNP mRNA expression level (markers of hypertrophy) were greater in cardiomyocytes treated with both neurotrophin-3 and endothelin-1 than in those stimulated with endothelin-1 alone. These findings demonstrate that neurotrophin-3 is a unique hypertrophic factor, which is paradoxically downregulated in cardiac hypertrophy and might counteract hypertrophic change.

AB - The neurotrophin family plays pivotal roles in the development of the nervous system. Recently, the role of the neurotrophin in non-neural tissue has been extensively investigated. Among them, neurotrophin-3 and its receptor TrkC are critical for embryonic heart development, though little is known about neurotrophin-3/TrkC function in adult heart. Moreover, the expressions of other neurotrophin and Trk families in the cardiovascular system have not been fully determined. In adult and neonatal rats, only TrkC mRNA was expressed more abundantly in heart than aorta among the neurotrophin receptors, while all neurotrophins were equally expressed in the cardiovascular system. Immunohistochemistry confirmed the protein expressions of neurotrophin-3/TrkC in rat ventricles. In primary-cultured rat cardiomyocytes, neurotrophin-3 strongly activated p38 mitogen-activated protein kinase, extracellular signal-regulated kinase 1/2, and Jun N-terminal kinase pathways in Western blot analysis. In Northern blot analysis, neurotrophin-3 strongly increased mRNA expressions of cardiac hypertrophic markers (skeletal α-actin and atrial natriuretic peptide) in cardiomocytes. [3H]-phenylalanine uptake into cardiomyocytes, myofilament reorganization, and cardiomyocyte size were also augmented with neurotrophin-3 stimulation, indicating that neurotrophin-3 is a novel cardiac hypertrophic factor. Unexpectedly, neurotrophin-3 was downregulated in cardiac hypertrophy induced by pressure overload (in vivo), and in cardiomyocyte hypertrophy evoked by endothelin-1 stimulation (in vitro). Interestingly, the cell size and BNP mRNA expression level (markers of hypertrophy) were greater in cardiomyocytes treated with both neurotrophin-3 and endothelin-1 than in those stimulated with endothelin-1 alone. These findings demonstrate that neurotrophin-3 is a unique hypertrophic factor, which is paradoxically downregulated in cardiac hypertrophy and might counteract hypertrophic change.

KW - Cardiac hypertrophy

KW - Cardiomyocyte

KW - Heart

KW - Neurotrophin-3

KW - TrkC

UR - http://www.scopus.com/inward/record.url?scp=34447521671&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34447521671&partnerID=8YFLogxK

U2 - 10.1016/j.lfs.2007.05.024

DO - 10.1016/j.lfs.2007.05.024

M3 - Article

C2 - 17628607

AN - SCOPUS:34447521671

VL - 81

SP - 385

EP - 392

JO - Life Sciences

JF - Life Sciences

SN - 0024-3205

IS - 5

ER -